Matches in SemOpenAlex for { <https://semopenalex.org/work/W4234815062> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W4234815062 endingPage "142" @default.
- W4234815062 startingPage "141" @default.
- W4234815062 abstract "This chapter provides the basic characteristics, side effects/toxicity, drug interactions, and dosing of the emtriva (emtricitabine). Changes in the structure of HIV reverse transcriptase leads to preferred incorporation of cytosine triphosphate and decreased incorporation of emtricitabine triphosphate, which allows transcription of DNA to continue. Resistance mutations include M184V. Emtricitabine is approved to be used in combination with other antiretrovirals for the treatment of HIV infection. It has activity against hepatitis B. Emtricitabine can be taken with or without food and is unaffected by pH. It should not be administered with any medication that contains lamivudine or emtricitabine, including Epivir, Combivir, Trizivir, Triumeq, Truvada, Descovy, Atripla, Complera, Odefsey, Stribild, or Genvoya. Emtricitabine is administered in a 200 mg tablet or in a clear orange liquid, which contains 10 mg/mL of emtricitabine. The recommended adult dose is 200 mg daily." @default.
- W4234815062 created "2022-05-12" @default.
- W4234815062 date "2017-08-30" @default.
- W4234815062 modified "2023-10-17" @default.
- W4234815062 title "EMTRIVA (Emtricitabine)" @default.
- W4234815062 doi "https://doi.org/10.1002/9781119220787.ch64" @default.
- W4234815062 hasPublicationYear "2017" @default.
- W4234815062 type Work @default.
- W4234815062 citedByCount "1" @default.
- W4234815062 countsByYear W42348150622023 @default.
- W4234815062 crossrefType "other" @default.
- W4234815062 hasConcept C104317684 @default.
- W4234815062 hasConcept C156719811 @default.
- W4234815062 hasConcept C159047783 @default.
- W4234815062 hasConcept C182707283 @default.
- W4234815062 hasConcept C185592680 @default.
- W4234815062 hasConcept C2522874641 @default.
- W4234815062 hasConcept C2777869810 @default.
- W4234815062 hasConcept C2779778239 @default.
- W4234815062 hasConcept C3020491458 @default.
- W4234815062 hasConcept C55493867 @default.
- W4234815062 hasConcept C67705224 @default.
- W4234815062 hasConcept C71924100 @default.
- W4234815062 hasConcept C98274493 @default.
- W4234815062 hasConceptScore W4234815062C104317684 @default.
- W4234815062 hasConceptScore W4234815062C156719811 @default.
- W4234815062 hasConceptScore W4234815062C159047783 @default.
- W4234815062 hasConceptScore W4234815062C182707283 @default.
- W4234815062 hasConceptScore W4234815062C185592680 @default.
- W4234815062 hasConceptScore W4234815062C2522874641 @default.
- W4234815062 hasConceptScore W4234815062C2777869810 @default.
- W4234815062 hasConceptScore W4234815062C2779778239 @default.
- W4234815062 hasConceptScore W4234815062C3020491458 @default.
- W4234815062 hasConceptScore W4234815062C55493867 @default.
- W4234815062 hasConceptScore W4234815062C67705224 @default.
- W4234815062 hasConceptScore W4234815062C71924100 @default.
- W4234815062 hasConceptScore W4234815062C98274493 @default.
- W4234815062 hasLocation W42348150621 @default.
- W4234815062 hasOpenAccess W4234815062 @default.
- W4234815062 hasPrimaryLocation W42348150621 @default.
- W4234815062 hasRelatedWork W1993951338 @default.
- W4234815062 hasRelatedWork W1996968222 @default.
- W4234815062 hasRelatedWork W2023705888 @default.
- W4234815062 hasRelatedWork W2023970350 @default.
- W4234815062 hasRelatedWork W2099736382 @default.
- W4234815062 hasRelatedWork W2107995001 @default.
- W4234815062 hasRelatedWork W2124976010 @default.
- W4234815062 hasRelatedWork W2149949524 @default.
- W4234815062 hasRelatedWork W2169087029 @default.
- W4234815062 hasRelatedWork W2885524194 @default.
- W4234815062 isParatext "false" @default.
- W4234815062 isRetracted "false" @default.
- W4234815062 workType "other" @default.